|Articles|February 1, 2020
- BioPharm International-02-01-2020
- Volume 33
- Issue 2
BioPharm International, February 2020 Issue (PDF)
Click the title above to open the BioPharm International February 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Managing Risk for Cell and Gene Therapy Logisticsabout 6 years ago
The Call for a Rapid Responseabout 6 years ago
Data Management Practicesabout 6 years ago
Biopharma Analysis Benefits from New Technology and Methodsabout 6 years ago
Cell Therapies: The Living End of Growth Opportunitiesabout 6 years ago
Fresh Thinking in Biologic Drug Formulationabout 6 years ago
The Need for Advanced Process Modeling for New Therapeutic Biologicsabout 6 years ago
Cell Culture Variables for Gene Therapy Vectorsabout 6 years ago
Challenges in Vector Purification for Gene TherapyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5